4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-040463
Director sold 2,850 shares at an average $30.14 ($85,909)
- Director acquired 2,850 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Swisher Daniel N JR Director | 2023-08-07 | Option exercise 10b5-1 | +2,200 | $6.55 | $14,410 | 2,200 | D |
| Swisher Daniel N JR Director | 2023-08-07 | Option exercise 10b5-1 | +650 | $5.86 | $3,809 | 2,850 | D |
| Swisher Daniel N JR Director | 2023-08-07 | Sale 10b5-1 | −2,200 | $30.14 | $66,308 | 650 | D |
| Swisher Daniel N JR Director | 2023-08-07 | Sale 10b5-1 | −650 | $30.16 | $19,601 | 0 | D |
| Derivatives | |||||||
| Swisher Daniel N JR Director | 2023-08-07 | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 5,300 | D | ||
| Swisher Daniel N JR Director | 2023-08-07 | Option exercise · Stock option (right to buy) 10b5-1 | −650 | 49,350 | D | ||
| Open-market sales · 2,850 sh · avg $30.14 · $85,909 | |||||||
Loading xslF345X05/ownership.xml…